
Tamara L. Lotan
Articles
-
Nov 20, 2023 |
urotoday.com | Tamara L. Lotan
Read the Full Video TranscriptAlicia Morgans: Hi. I'm so excited to be here today with Professor Tamara Lotan, who is joining me from Johns Hopkins University. Thank you so much for being here. Tamara Lotan: Great. Thanks for having me. Alicia Morgans: Wonderful. Tamara, you are a pathologist.
-
Oct 31, 2023 |
nature.com | Joakin O Mori |W. Nathaniel Brennen |Mindy K Graham |Tamara L. Lotan |Srinivasan Yegnasubramanian |William Nelson | +2 more
AbstractThe stromal component of the tumour microenvironment in primary and metastatic prostate cancer can influence and promote disease progression. Within the prostatic stroma, fibroblasts are one of the most prevalent cell types associated with precancerous and cancerous lesions; they have a vital role in the structural composition, organization and integrity of the extracellular matrix.
-
Aug 17, 2023 |
urotoday.com | Tamara L. Lotan
Read the Full Video TranscriptAndrea Miyahira: Hi everyone, I'm Andrea Miyahira here at the Prostate Cancer Foundation. Thanks for joining us today. Today I'm here with Dr. Tamara Lotan, a professor at Johns Hopkins. She'll be discussing her group's recent paper, "Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images." It was recently published in Modern Pathology. Thanks so much for joining me today, Dr. Lotan. Tamara Lotan: Great, thank you so much for having me.
-
Apr 3, 2023 |
nature.com | Eugene Shenderov |Tamara L. Lotan |Hao Wang |Hongkai Ji |Sarah Church |Paul Fields | +1 more
Author notesEmmanuel S. AntonarakisPresent address: University of Minnesota Masonic Cancer Center, Minneapolis, MN, USAAuthors and AffiliationsDepartment of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USAEugene Shenderov, Angelo M. De Marzo, Tamara L. Lotan, Sin Chan, Carolyn Chapman, Samuel R. Denmeade, Kenneth J. Pienta, Drew M. Pardoll & Emmanuel S.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →